Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7641906
Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis
granted -
US 7641909
Avirulent, immunogenic flavivirus chimeras
granted -
US 7638333
Anthrax vaccine
granted -
US 7638134
Insertion sites in fowlpox vectors
granted -
US 7635485
Method of accelerated vaccination against Ebola viruses
granted -
US 7635486
Recombinant lipidated PsaA protein, methods of preparation and use
granted -
US 7635476
Anti-hepatitis a virus antibodies
granted -
US 7635688
Development of a preventive vaccine for filovirus infection in primates
granted -
US 7632508
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
granted -
US 7632510
Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
granted -
US 7632659
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
granted -
US 7625736
Methods for preparing immunogenic conjugates
granted -
US 7625571
Transformed bacteria producing CS6 antigens as vaccines
granted -
US 7622272
Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology
granted -
US 7622123
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
granted -
US 7622113
Monoclonal antibodies that bind or neutralize dengue virus
granted -
US 7619057
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
granted -
US 7618632
Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
granted -
US 7618623
Hybrid adeno-retroviral vector for the transfection of cells
granted -
US 7615227
Use of CpG oligodeoxynucleotides to induce angiogenesis
granted -
US 7612044
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7608422
Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhibitory/instability regions
granted -
US 7605125
DNA-binding polyamide drug conjugates
granted -
US 7605127
Truncated hepatocyte growth factor variant protein HGF/NK2
granted